A detailed history of Deutsche Bank Ag\ transactions in Nevro Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 79,840 shares of NVRO stock, worth $363,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,840
Previous 74,573 7.06%
Holding current value
$363,272
Previous $627,000 29.03%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.71 - $10.1 $24,807 - $53,196
5,267 Added 7.06%
79,840 $445,000
Q2 2024

Aug 14, 2024

SELL
$7.96 - $13.59 $371,166 - $633,688
-46,629 Reduced 38.47%
74,573 $627,000
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $5,546 - $8,499
409 Added 0.34%
121,202 $1.75 Million
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $1.45 Million - $2.28 Million
102,062 Added 544.88%
120,793 $2.6 Million
Q3 2023

Nov 09, 2023

SELL
$18.22 - $25.85 $1.8 Million - $2.55 Million
-98,822 Reduced 84.07%
18,731 $360,000
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $238,007 - $413,725
-10,522 Reduced 8.22%
117,553 $2.99 Million
Q1 2023

May 15, 2023

SELL
$30.17 - $41.11 $2.35 Million - $3.21 Million
-78,055 Reduced 37.87%
128,075 $4.63 Million
Q4 2022

Feb 13, 2023

BUY
$36.43 - $49.4 $1.55 Million - $2.1 Million
42,583 Added 26.04%
206,130 $8.16 Million
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $1.66 Million - $2.17 Million
40,902 Added 33.35%
163,547 $7.62 Million
Q2 2022

Aug 11, 2022

SELL
$40.85 - $77.67 $10.1 Million - $19.1 Million
-246,383 Reduced 66.77%
122,645 $5.38 Million
Q1 2022

May 13, 2022

BUY
$59.95 - $92.06 $19.3 Million - $29.7 Million
322,435 Added 692.02%
369,028 $26.7 Million
Q4 2021

Feb 11, 2022

SELL
$81.07 - $121.29 $31,374 - $46,939
-387 Reduced 0.82%
46,593 $3.78 Million
Q3 2021

Nov 04, 2021

SELL
$101.99 - $166.36 $3.64 Million - $5.94 Million
-35,708 Reduced 43.18%
46,980 $5.47 Million
Q2 2021

Aug 11, 2021

BUY
$141.6 - $179.06 $2.26 Million - $2.86 Million
15,988 Added 23.97%
82,688 $13.7 Million
Q1 2021

May 13, 2021

BUY
$132.81 - $182.18 $799,781 - $1.1 Million
6,022 Added 9.92%
66,700 $9.3 Million
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $978,519 - $1.31 Million
7,082 Added 13.21%
60,678 $10.5 Million
Q3 2020

Nov 12, 2020

BUY
$114.09 - $145.51 $503,022 - $641,553
4,409 Added 8.96%
53,596 $7.47 Million
Q2 2020

Aug 13, 2020

SELL
$89.45 - $129.85 $2.15 Million - $3.12 Million
-24,008 Reduced 32.8%
49,187 $5.88 Million
Q1 2020

May 14, 2020

BUY
$70.23 - $144.31 $2.58 Million - $5.31 Million
36,766 Added 100.93%
73,195 $7.32 Million
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $1.82 Million - $2.8 Million
23,823 Added 188.98%
36,429 $4.28 Million
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $8.5 Million - $12.6 Million
-138,153 Reduced 91.64%
12,606 $1.08 Million
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $16.6 Million - $19.2 Million
-286,403 Reduced 65.51%
150,759 $9.77 Million
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $4.6 Million - $8.11 Million
129,556 Added 42.12%
437,162 $27.3 Million
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $1.8 Million - $2.86 Million
50,763 Added 19.76%
307,606 $12 Million
Q3 2018

Dec 21, 2021

BUY
$44.22 - $75.47 $397,980 - $679,230
9,000 Added 3.63%
256,843 $14.6 Million
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $678,600 - $1.16 Million
-15,346 Reduced 5.83%
247,843 $14.1 Million
Q2 2018

Apr 21, 2020

BUY
$72.38 - $92.5 $869,500 - $1.11 Million
12,013 Added 4.78%
263,189 $21 Million
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $3.71 Million - $4.74 Million
51,289 Added 25.66%
251,176 $20.1 Million
Q1 2018

Oct 18, 2019

BUY
$69.46 - $88.57 $728,982 - $929,542
10,495 Added 5.54%
199,887 $17.3 Million
Q1 2018

May 15, 2018

SELL
$69.46 - $88.57 $39.8 Million - $50.8 Million
-573,690 Reduced 75.18%
189,392 $16.4 Million
Q4 2017

Feb 14, 2018

SELL
$65.94 - $93.31 $23.9 Million - $33.9 Million
-363,006 Reduced 32.24%
763,082 $52.7 Million
Q3 2017

Nov 14, 2017

BUY
$80.87 - $91.08 $91.1 Million - $103 Million
1,126,088
1,126,088 $102 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $161M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.